Kenjiro Sawada

2019 - 2022 Elucidation of the regulatory mechanism of ovarian cancer progression and endometriosis carcinogenesis by deubiquitinating enzymes using a forward genetics approach.

2019 - 2022 The role of lectins in the development of endometriosis.

2018 - 2021 The development of a novel microRNA replacement therapy for ovarian cancer - a potential of patient derived-exosomes as a carrier.

2017 - 2020 The mechanism of immune escape by myeloid-derived suppressor cells and cancer stem cells in ovarian cancer.

2017 - 2020 Sleeping Beauty Transposon mutagenesis screen for identifying driver genes in uterine leiomyosarcoma

2016 - 2019 Pathogenesis of endometriosis via endometrial stromal cell derived exosomes.

2014 - 2017 Why is the treatment of peritoneal dissemination so difficult? Analyses focusing on microRNA and exosome.

2014 - 2017 Role of MDSC-mediated premetastatic niche formation in the resistance of Anti-angiogenic agent.

2014 - 2017 Analysis of the pathogenesis of endometriosis focusing on intracellular communications.

2013 - 2016 Investigate the adhesion molecules that control the progression of endometriosis.

2012 - 2015 Exploit of new strategy of prediction, prevention, treatment of preeclampsia using

2012 - 2015 Devoleping a novel anti-angiogenic therapy focused on placental growth factor secreted by ovarian cancer cells

2012 - 2014 Establishment and functional analysis of induced pluripotent cancer cells in ovarian cancer

2010 - 2014 The identification of drug resistance in ovarian cancer : new insights form metabolomics and autophagy

2011 - 2013 Potential role of mTORC2 as a therapeutic target in epithelial ovarian cancer

2011 - 2013 Identification of micro RNAs which affected by tumor microenvironments of ovarian cancer and analysis of a potential as a therapeutic target

2011 - 2013 The molecular analysis of placental abruption using in vitro placental model

2009 - 2010 卵巣癌の間葉系幹細胞の同定と機能解析-その分子標的治療に向けての基礎的研究

2009 - 2010 Identification of microRNA which regulates peritoneal dissemination of ovarian cancer

2008 - 2010 Uterine leiomyoma and metabolic syndrome-a new therapeutic strategy

2007 - 2008 Analysis of the adhesion molecule which is important for ovarian cancer dissemination